170 related articles for article (PubMed ID: 38066476)
21. MVP immunohistochemistry is a useful adjunct in distinguishing leiomyosarcoma from leiomyoma and leiomyoma with bizarre nuclei.
Lintel NJ; Luebker SA; Lele SM; Koepsell SA
Hum Pathol; 2018 Mar; 73():122-127. PubMed ID: 29307622
[TBL] [Abstract][Full Text] [Related]
22. [Differential diagnosis of cellular leiomyomas and leiomyoplastic sarcomas].
Cupr Z; Rohanova M; Holle V; Sikula M
Zentralbl Gynakol; 1972 Jan; 94(3):101-8. PubMed ID: 5017233
[No Abstract] [Full Text] [Related]
23. Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays.
Yatsenko SA; Mittal P; Wood-Trageser MA; Jones MW; Surti U; Edwards RP; Sood AK; Rajkovic A
Fertil Steril; 2017 Feb; 107(2):457-466.e9. PubMed ID: 27889101
[TBL] [Abstract][Full Text] [Related]
24. [Differential diagnosis of cellular fibroleiomyoma and fibroleiomyosarcoma in young women. Case report and clinico-histopathological considerations].
Leone U
Ann Ostet Ginecol Med Perinat; 1974 Feb; 94(2):137-41. PubMed ID: 4816206
[No Abstract] [Full Text] [Related]
25. STMN1 and MKI67 Are Upregulated in Uterine Leiomyosarcoma and Are Potential Biomarkers for its Diagnosis.
Hu X; Zhang H; Zheng X; Lin Z; Feng G; Chen Y; Pan Q; Ni F
Med Sci Monit; 2020 May; 26():e923749. PubMed ID: 32425177
[TBL] [Abstract][Full Text] [Related]
26. Clinical application of diffusion-weighted imaging for preoperative differentiation between uterine leiomyoma and leiomyosarcoma.
Sato K; Yuasa N; Fujita M; Fukushima Y
Am J Obstet Gynecol; 2014 Apr; 210(4):368.e1-368.e8. PubMed ID: 24368137
[TBL] [Abstract][Full Text] [Related]
27. Different characteristics of mitochondrial microsatellite instability between uterine leiomyomas and leiomyosarcomas.
Lee JH; Ryu TY; Cho CH; Kim DK
Pathol Oncol Res; 2011 Jun; 17(2):201-5. PubMed ID: 20853077
[TBL] [Abstract][Full Text] [Related]
28. Atomic force microscopy: a promising aid in diagnosis of uterine smooth muscle neoplasms.
Peñuela LA; Fulcheri E; Vellone VG; Fiocca R; Vigliercio GM; Raiteri R; Ferrero S
Am J Obstet Gynecol; 2019 Oct; 221(4):362-364. PubMed ID: 31121140
[No Abstract] [Full Text] [Related]
29. Molecular Bio-Imaging Probe for Non-Invasive Differentiation Between Human Leiomyoma Versus Leiomyosarcoma.
Shalaby S; Khater M; Laknaur A; Arbab A; Al-Hendy A
Reprod Sci; 2020 Feb; 27(2):644-654. PubMed ID: 31925772
[TBL] [Abstract][Full Text] [Related]
30. MRI of uterine leiomyosarcoma.
Pattani SJ; Kier R; Deal R; Luchansky E
Magn Reson Imaging; 1995; 13(2):331-3. PubMed ID: 7739376
[TBL] [Abstract][Full Text] [Related]
31. Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors.
Croce S; Ducoulombier A; Ribeiro A; Lesluyes T; Noel JC; Amant F; Guillou L; Stoeckle E; Devouassoux-Shisheboran M; Penel N; Floquet A; Arnould L; Guyon F; Mishellany F; Chakiba C; Cuppens T; Zikan M; Leroux A; Frouin E; Farre I; Genestie C; Valo I; MacGrogan G; Chibon F
Mod Pathol; 2018 May; 31(5):816-828. PubMed ID: 29327710
[TBL] [Abstract][Full Text] [Related]
32. Loss of ATRX/DAXX expression and alternative lengthening of telomeres in uterine leiomyomas.
Ahvenainen TV; Mäkinen NM; von Nandelstadh P; Vahteristo MEA; Pasanen AM; Bützow RC; Vahteristo PM
Cancer; 2018 Dec; 124(24):4650-4656. PubMed ID: 30423196
[TBL] [Abstract][Full Text] [Related]
33. Loss of dystrophin is common in uterine leiomyosarcoma: a potential biomarker for clinical application.
Vadasz B; Felicelli C; Feng Y; Yin P; Zhang Q; Bulun S; Wei JJ
Hum Pathol; 2023 Apr; 134():85-91. PubMed ID: 36549601
[TBL] [Abstract][Full Text] [Related]
34. [The loss of heterozygosity and microsatellite instability analysis in differential diagnostics of leiomyosarcoma and proliferative leiomyoma of the uterus].
Shikeeva AA; Kekeeva TV; Zavalishina LÉ; Andreeva IuIu; Frank GA
Arkh Patol; 2011; 73(4):47-50. PubMed ID: 22164433
[TBL] [Abstract][Full Text] [Related]
35. Potential diagnostic biomarkers: differential expression of LMP2/β1i and cyclin B1 in human uterine leiomyosarcoma.
Hayashi T; Horiuchi A; Sano K; Hiraoka N; Ichimura T; Sudo T; Ishiko O; Yaegashi N; Aburatani H; Konishi I
Tumori; 2014; 100(4):99e-106e. PubMed ID: 25296613
[TBL] [Abstract][Full Text] [Related]
36. Differential diagnosis between uterine sarcoma and leiomyoma using preoperative clinical characteristics.
Cho HY; Kim K; Kim YB; No JH
J Obstet Gynaecol Res; 2016 Mar; 42(3):313-8. PubMed ID: 26695124
[TBL] [Abstract][Full Text] [Related]
37. Chance finding of a leiomyosarcoma in hysteroscopic resection of a myoma.
Römer T; Schwesinger G
Acta Obstet Gynecol Scand; 2002 Nov; 81(11):1078-9. PubMed ID: 12421178
[No Abstract] [Full Text] [Related]
38. [Benign metastasizing leiomyoma and leiomyosarcoma (author's transl)].
Brossel R; Mathon H; Schlienger M
J Gynecol Obstet Biol Reprod (Paris); 1981; 10(3):211-8. PubMed ID: 7021653
[No Abstract] [Full Text] [Related]
39. [The differential diagnosis between uterine leiomyosarcoma and the special subtypes of leiomyoma].
Zhu XQ; Shi YF; Cheng XD; Wu YZ
Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(16):1419-21. PubMed ID: 14521746
[TBL] [Abstract][Full Text] [Related]
40. Development of Uterine Leiomyosarcoma During Follow-up After Caesarean Section in a Woman With Uterine Leiomyoma.
Watanabe K; Hayashi T; Katsumata M; Sano K; Abiko K; Konishi I
Anticancer Res; 2021 Jun; 41(6):3001-3010. PubMed ID: 34083291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
